(IBDQ) iShares iBonds Dec 2025 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46434VBD10

IBDQ: Investment-Grade Corporate Bonds, Fixed Income Securities, 2025 Maturity

The iShares iBonds Dec2025 Term Corporate ETF is a targeted maturity ETF that invests in a diversified portfolio of U.S. dollar-denominated, investment-grade corporate bonds with maturities between January 1, 2025, and December 15, 2025. This ETF is designed to provide investors with a predictable income stream and return of principal at maturity.

By investing at least 80% of its assets in the component securities of the underlying index and at least 90% in fixed income securities, the fund maintains a high level of consistency with its benchmark. The underlying index is composed of high-quality corporate bonds, which reduces the credit risk associated with the investment.

With an Assets Under Management (AUM) of $3.064 billion, the ETF has achieved a significant scale, which can lead to lower expense ratios and improved liquidity for investors. As a Target Maturity ETF, IBDQ offers a unique value proposition for investors seeking to match their investment horizon with the maturity profile of the underlying bonds.

From a technical analysis perspective, the ETFs price action indicates a stable trend, with the short-term (20-day) and medium-term (50-day) moving averages converging around $25.08 and $25.01, respectively. The longer-term (200-day) moving average at $24.68 suggests a gradual uptrend. The Average True Range (ATR) of 0.02, equivalent to 0.07%, indicates relatively low volatility.

Combining the technical and fundamental data, a forecast for IBDQ could be as follows: As the ETF approaches maturity in December 2025, we can expect the price to remain stable, with a potential slight increase due to the accretion of the bond portfolio. Assuming interest rates remain relatively stable, the ETFs price is likely to continue to track its net asset value (NAV) closely. With a current price of $25.11, we can expect a slight appreciation towards $25.20-$25.30 over the next 6-12 months, driven by the gradual reduction in duration and the associated decrease in interest rate risk.

Investors should be aware that the ETFs performance is closely tied to the credit quality of the underlying bonds and the overall direction of interest rates. As such, it is essential to monitor the ETFs holdings and market conditions closely to ensure that the investment remains aligned with their overall investment objectives and risk tolerance.

Additional Sources for IBDQ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IBDQ ETF Overview

Market Cap in USD 3,038m
Category Target Maturity
TER 0.10%
IPO / Inception 2015-03-11

IBDQ ETF Ratings

Growth Rating 36.0
Fundamental -
Dividend Rating 68.0
Rel. Strength -7.52
Analysts -
Fair Price Momentum 24.60 USD
Fair Price DCF -

IBDQ Dividends

Dividend Yield 12m 3.98%
Yield on Cost 5y 4.25%
Annual Growth 5y 6.80%
Payout Consistency 94.9%
Payout Ratio %

IBDQ Growth Ratios

Growth Correlation 3m 99.2%
Growth Correlation 12m 100%
Growth Correlation 5y 25.7%
CAGR 5y 1.54%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m 8.79
Alpha 1.15
Beta 0.003
Volatility 1.22%
Current Volume 291.6k
Average Volume 20d 413.8k
What is the price of IBDQ shares?
As of June 29, 2025, the stock is trading at USD 25.16 with a total of 291,648 shares traded.
Over the past week, the price has changed by +0.08%, over one month by +0.39%, over three months by +1.12% and over the past year by +5.38%.
Is iShares iBonds Dec 2025 a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, iShares iBonds Dec 2025 (NYSE ARCA:IBDQ) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.99 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDQ is around 24.60 USD . This means that IBDQ is currently overvalued and has a potential downside of -2.23%.
Is IBDQ a buy, sell or hold?
iShares iBonds Dec 2025 has no consensus analysts rating.
What are the forecasts for IBDQ share price target?
According to our own proprietary Forecast Model, IBDQ iShares iBonds Dec 2025 will be worth about 26.6 in June 2026. The stock is currently trading at 25.16. This means that the stock has a potential upside of +5.6%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.6 5.6%